Global Atopic Dermatitis Drugs Market: Overview
A huge amount of the world’s population is affected by atopic dermatitis (AD), which is a common type of eczema. Mainly infants and children are mostly affected by atopic dermatitis. The key factor for the market growth is the increasing occurrence of atopic dermatitis. The exact cause for the condition is unknown but it is speculated it may be a result of environmental and genetic factors.
Global Atopic Dermatitis Drugs Market: Growth Factors
Atopic dermatitis drugs market anticipate growing at an average pace. Key drivers for the market growth are an introduction to new biologics and treatments, replacement of primary and second-line therapies with premium-priced drugs, rise in the incidence rates of atopic dermatitis, and improving diagnostics. In recent years, increasing awareness about treatment available for the disease has fuelled market growth. Governments of different regions are taking initiatives to provide affordable treatments to patients and favorable reimbursement policies are triggering further growth of the market. Eucrisa and Dupixent are targeted therapies that are gaining acceptance, which contributes to market growth. Therapeutics cost high thus limiting market development; however, measures are being taken to make the treatment facilities affordable and favorable reimbursement scenarios are also being offered.
Global Atopic Dermatitis Drugs Market: Segmentation
Broad segmentation of atopic dermatitis drugs market includes the drug class and route of administration. The drug class includes calcineurin inhibitors, biologics, corticosteroids, PDE4 inhibitors, and others. Corticosteroids play a major role in the atopic dermatitis treatment. This drug class is considered as the primary treatment thus corticosteroids segment anticipates holding the majority of the market shares in the upcoming years. In the coming years, the new drug classes PDE4 inhibitors and biologics expect to gain acceptance in the treatment of atopic dermatitis. Based on the route of administration, the market is categorized into oral, injectable, and topical. Topical products anticipate leading the segment. Among the prescribed medications for atopic dermatitis treatment, topical corticosteroids were the widely prescribed ones and they are mainly used in combination with emollients or moisturizers for effective output.
Global Atopic Dermatitis Drugs Market: Regional Analysis
Region-wise, North America anticipates leading the atopic dermatitis market. The U.S. contributes majorly to the North American atopic dermatitis drugs market owing to increasing incidences of atopic dermatitis, high diagnosis rate, and increased awareness, increased healthcare expenditure, favorable reimbursement policies, and increasing initiatives toward introducing new biologic treatments.
Asia Pacific atopic dermatitis drugs market anticipates witnessing a good growth rate in the coming years. Factors contributing to the market growth are growing spendings on healthcare, rise in the unmet patient clinical needs, and the growing research and development activities for introducing effective treatments. Europe is also expected to show a healthy market growth rate in the future, where in the UK and Spain anticipate holding a prominent position.
Global Atopic Dermatitis Drugs Market: Competitive Players
Industry players in the atopic dermatitis drugs market include Allergan Plc., Bristol-Myers Squibb, Meda Pharmaceuticals, Pfizer, Regeneron Pharmaceuticals, Sanofi SA, Novartis International AG, Bayer AG, Anacor Pharmaceutical Inc., and Astellas Pharma, Inc., among others.
Global Atopic Dermatitis Drugs Market: Regional Segment Analysis
- North America
- The U.S.
- Europe
- The UK
- France
- Germany
- The Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
What Reports Provides
- Full in-depth analysis of the parent market
- Important changes in market dynamics
- Segmentation details of the market
- Former, on-going, and projected market analysis in terms of volume and value
- Assessment of niche industry developments
- Market share analysis
- Key strategies of major players
- Emerging segments and regional markets
- Testimonials to companies in order to fortify their foothold in the market.
